|
Volumn 1, Issue 1, 2009, Pages 29-35
|
Repaglinide-loaded long-circulating biodegradable nanoparticles: rational approach for the management of type 2 diabetes mellitus.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
CARBAMIC ACID DERIVATIVE;
LACTIC ACID;
MACROGOL DERIVATIVE;
MONOMETHOXYPOLYETHYLENE GLYCOL;
NANOPARTICLE;
PIPERIDINE DERIVATIVE;
POLYGLYCOLIC ACID;
POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER;
POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;
REPAGLINIDE;
ANIMAL;
ARTICLE;
BLOOD;
CHEMISTRY;
DELAYED RELEASE FORMULATION;
DISEASE MODEL;
DRUG EFFECT;
DRUG FORMULATION;
EXPERIMENTAL DIABETES MELLITUS;
GLUCOSE BLOOD LEVEL;
MALE;
METABOLISM;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL DRUG ADMINISTRATION;
PARTICLE SIZE;
RAT;
SOLUBILITY;
SPRAGUE DAWLEY RAT;
ADMINISTRATION, ORAL;
ANIMALS;
BLOOD GLUCOSE;
CARBAMATES;
CHEMISTRY, PHARMACEUTICAL;
DELAYED-ACTION PREPARATIONS;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETES MELLITUS, TYPE 2;
DISEASE MODELS, ANIMAL;
DRUG COMPOUNDING;
HYPOGLYCEMIC AGENTS;
LACTIC ACID;
MALE;
NANOPARTICLES;
PARTICLE SIZE;
PIPERIDINES;
POLYETHYLENE GLYCOLS;
POLYGLYCOLIC ACID;
RATS;
RATS, SPRAGUE-DAWLEY;
SOLUBILITY;
MLCS;
MLOWN;
|
EID: 67649121328
PISSN: None
EISSN: 17530407
Source Type: Journal
DOI: 10.1111/j.1753-0407.2008.00001.x Document Type: Article |
Times cited : (21)
|
References (0)
|